IBC Legal Conferences will be holding its 8th Annual Pharmaceutical Law Academy on September 6-7, 2011 in London, UK. IBC Legal faculty will offer presentations on the following topics:• Clinical trials;
• Legal aspects of paediatric medicines regulation;
• EU vertical and horizontal block exemption regulations -- Implications for the pharmaceutical industry;
• Generics and biosimilars -- Regulatory data protection and other related issues;
• Regulatory perspective -- Pharmacovigilance & risk management plans;
• Regulatory case study & debate on case study;
• Research and development -- The issues;
• SPCs -- European case law update;
• Patent update;
• Dealing effectively with parallel trading issues;
• Follow-on Products;
• Pharma sector competition law developments; and
• Competition law and IP rights case study & debate on case study.
Superhit News
-
US health regulator USFDA has issued a warning letter to German drug firm Fresenius Kabi AG for lapses at its drug manufacturing fac... -
Goods and Service Tax (GST) is high on the agenda for the new government and its rollout is a priority. GST will benefit the Indian pharma... -
Rib-X Pharmaceuticals, Inc. announced today the signature of an exclusive worldwide research collaboration agreement and option for license ...
-
Physiomics: Reports difficult trading but highlights growing interest from big pharmaceutical groupsPhysiomics ( LON:PYC ) said that trading conditions were difficult in the six months ended 31 December 2010, but it believes it is in a be...
-
Hindusthan National Glass and Industries Ltd is expected to finalize a strategic overseas acquisition in the pharmaceuticals space in the n...
-
The Minister of State (Health and Family Welfare), Sh Ashwini Kumar Choubey through a written reply in the Lok Sabha informed about th... -
The government is hoping to see the implementation of the track and trace system for domestic and export supply chain in another one y... -
India's Central Drugs Standard Control Organization (CDSCO) has suspended the manufacturing of eye drops at the Chennai-based firm after... -
Diclofenac injection is a painkiller which is manufactured by Themis Medicare Ltd and marketed by Novartis India under the brand name ... -
Amylin Pharmaceuticals, Inc. AMLN +16.15% and Alkermes plc ALKS +4.61% today announced that the U.S. Food and Drug Administration (FDA) has ...
No comments:
Post a Comment